Cellectar Biosciences Inc

Research Cellectar Biosciences Inc (CLRB) on Bullrun: market cap USD 11.02M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCLRB
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 11.02M
• Financial periodFY2025
• Net income-USD 21.79M
• Free cash flow-USD 23.12M

Valuation Snapshot

latest market cap is USD 11.02M.

About Cellectar Biosciences Inc

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies;

Frequently asked questions

What is Cellectar Biosciences Inc's market cap?

Cellectar Biosciences Inc's market capitalization is USD 11.02M.

What does Cellectar Biosciences Inc do?

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.